Dr. Andreas Bröhl is a Principal Scientist in Analytics for Drug Development at Bayer, where they lead an Analytical Development Lab supporting clinical drug development. With a PhD in Chemistry from the University of Cologne, where they graduated summa cum laude, Dr. Bröhl has over seven years of experience in the pharmaceutical industry, focusing on analytical development and CMC. They have held various positions in prestigious institutions, including University of Notre Dame and Imperial College London, contributing to advancements in protein stabilization and molecular dynamics simulations. Dr. Bröhl is committed to collaboration in the field of transforming molecules into medicines.
This person is not in the org chart
This person is not in any teams
This person is not in any offices